نتائج البحث - Slamon, Dennis
- يعرض 1 - 20 نتائج من 82
- اذهب إلى الاصفحة التالية
-
1
-
2
-
3
-
4
The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers حسب Oh, Juliana J., Koegel, Ashley, Phan, Diana T., Razfar, Ali, Slamon, Dennis J.
منشور في 2007نص -
5
-
6
-
7
Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer حسب Wu, Yanyuan, Mohamed, Hezla, Chillar, Ram, Ali, Ishrat, Clayton, Sheila, Slamon, Dennis, Vadgama, Jaydutt V
منشور في 2008نص -
8
Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab resistant HER2-overexpressing breast cancer cells حسب Wu, Yanyuan, Ginther, Charles, Kim, Juri, Mosher, Nicole, Chung, Seyung, Slamon, Dennis, Vadgama, Jaydutt V.
منشور في 2012نص -
9
-
10
CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors حسب Xu, Jinhua, Huo, Dezheng, Chen, Yinghua, Nwachukwu, Chika, Collins, Cindy, Rowell, Janelle, Slamon, Dennis J., Olopade, Olufunmilayo I.
منشور في 2009نص -
11
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies حسب Esteva, Francisco J, Cheli, Carol D, Fritsche, Herbert, Fornier, Monica, Slamon, Dennis, Thiel, Robert P, Luftner, Diana, Ghani, Farooq
منشور في 2005نص -
12
Inhibitors of Protein Geranylgeranyltransferase I and Rab Geranylgeranyltransferase Identified from a Library of Allenoate-derived Compounds حسب Watanabe, Masaru, Fiji, Hannah D. G., Guo, Lea, Chan, Lai, Kinderman, Sape S., Slamon, Dennis J., Kwon, Ohyun, Tamanoi, Fuyuhiko
منشور في 2008نص -
13
Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient حسب Lu, Nu T., Raizer, Jeffrey, Gabor, Erwin P., Liu, Natalie M., Vu, James Q., Slamon, Dennis J., Barstis, John L.
منشور في 2015نص -
14
-
15
Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study حسب Britten, Carolyn D, Gomes, Antoinette S, Wainberg, Zev A, Elashoff, David, Amado, Rafael, Xin, Yan, Busuttil, Ronald W, Slamon, Dennis J, Finn, Richard S
منشور في 2012نص -
16
-
17
A Phase I/II Trial of Trastuzumab plus Erlotinib in Metastatic HER2-Positive Breast Cancer: A Dual ErbB Targeted Approach حسب Britten, Carolyn D., Finn, Richard S., Bosserman, Linda D., Wong, Steven G., Press, Michael F., Malik, Mubashira, Lum, Bert L., Slamon, Dennis J.
منشور في 2009نص -
18
Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer حسب Fejzo, Marlena S., Anderson, Lee, von Euw, Erika M., Kalous, Ondrej, Avliyakulov, Nuraly K., Haykinson, Michael J., Konecny, Gottfried E., Finn, Richard S., Slamon, Dennis J.
منشور في 2013نص -
19
Pleiotrophin mediates hematopoietic regeneration via activation of RAS حسب Himburg, Heather A., Yan, Xiao, Doan, Phuong L., Quarmyne, Mamle, Micewicz, Eva, McBride, William, Chao, Nelson J., Slamon, Dennis J., Chute, John P.
منشور في 2014نص -
20
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-posit... حسب Hurvitz, Sara A, Bosserman, Linda D, Chan, David, Hagenstad, Christopher T, Kass, Frederick C, Smith, Frederick P, Rodriguez, Gladys I, Childs, Barrett H, Slamon, Dennis J
منشور في 2014نص